Used in the synthesis of pharmaceutical agents targeting neurological disorders, particularly as an intermediate in developing serotonin receptor modulators. Its structural configuration supports high selectivity in binding, making it valuable in creating drugs for anxiety, depression, and migraine treatment. The compound’s chiral center enhances its biological activity, allowing lower therapeutic doses and reduced side effects. It is also explored in the development of anti-inflammatory agents due to its interaction with central nervous system pathways involved in pain modulation.